Free Trial

Avidity Biosciences (RNA) SEC Filings & 10K Form

Avidity Biosciences logo
$29.13 -0.23 (-0.78%)
Closing price 07/3/2025 02:28 PM Eastern
Extended Trading
$29.13 0.00 (0.00%)
As of 07/3/2025 04:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Avidity Biosciences SEC Filings

DateFilerForm TypeView
06/18/2025
5:02 PM
Avidity Biosciences (Issuer)
Gallagher Kathleen P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2025
5:30 PM
Avidity Biosciences (Issuer)
Skerjanec Simona (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2025
5:35 PM
Avidity Biosciences (Issuer)
LEVIN ARTHUR A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2025
5:37 PM
Avidity Biosciences (Issuer)
Kaye Edward M. MD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2025
5:40 PM
Avidity Biosciences (Issuer)
BOESS CARSTEN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2025
5:42 PM
Avidity Biosciences (Issuer)
Henig Noreen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2025
5:18 PM
Avidity Biosciences (Issuer)
Flanagan W. Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2025
5:20 PM
Avidity Biosciences (Issuer)
Kim Jean Jinsun (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2025
5:24 PM
Avidity Biosciences (Issuer)
Thompson Tamar (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2025
5:26 PM
Avidity Biosciences (Issuer)
WILSON TROY EDWARD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2025
3:31 PM
Avidity Biosciences (Subject)
Flanagan W. Michael (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/10/2025
3:51 PM
Avidity Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/09/2025
6:05 AM
Avidity Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/04/2025
3:48 PM
Avidity Biosciences (Issuer)
Gallagher Kathleen P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2025
3:37 PM
Avidity Biosciences (Subject)
Gallagher Kathleen P. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/14/2025
11:15 AM
Avidity Biosciences (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
Form SCHEDULE 13G/A
05/12/2025
9:44 AM
Avidity Biosciences (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SCHEDULE 13G/A
05/02/2025
6:55 PM
Avidity Biosciences (Issuer)
Gallagher Kathleen P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2025
3:56 PM
Avidity Biosciences (Issuer)
Gallagher Kathleen P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/25/2025
7:50 AM
Avidity Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/21/2025
5:38 PM
Avidity Biosciences (Issuer)
MacLean Michael F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/21/2025
5:40 PM
Avidity Biosciences (Issuer)
Flanagan W. Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/21/2025
5:42 PM
Avidity Biosciences (Issuer)
Boyce Sarah (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/21/2025
5:44 PM
Avidity Biosciences (Issuer)
Hughes Steven George (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/21/2025
5:36 PM
Avidity Biosciences (Issuer)
McCarthy Teresa (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/17/2025
6:02 AM
Avidity Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/12/2025
3:23 PM
Avidity Biosciences (Issuer)
Flanagan W. Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2025
3:35 PM
Avidity Biosciences (Subject)
Flanagan W. Michael (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/04/2025
5:17 PM
Avidity Biosciences (Issuer)
Gallagher Kathleen P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2025
3:59 PM
Avidity Biosciences (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/27/2025
3:13 PM
Avidity Biosciences (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/14/2025
10:24 AM
Avidity Biosciences (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
Form SCHEDULE 13G
02/05/2025
4:01 PM
Avidity Biosciences (Issuer)
Gallagher Kathleen P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2025
3:34 PM
Avidity Biosciences (Subject)
Gallagher Kathleen P. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/23/2025
7:12 PM
Avidity Biosciences (Issuer)
Flanagan W. Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
7:14 PM
Avidity Biosciences (Issuer)
McCarthy Teresa (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
7:15 PM
Avidity Biosciences (Issuer)
MacLean Michael F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
7:17 PM
Avidity Biosciences (Issuer)
LEVIN ARTHUR A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
7:06 PM
Avidity Biosciences (Issuer)
Hughes Steven George (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
7:08 PM
Avidity Biosciences (Issuer)
Gallagher Kathleen P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
7:10 PM
Avidity Biosciences (Issuer)
Boyce Sarah (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Elon’s BIGGEST warning yet? (Ad)

Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough.

Click here to see why Tesla's about to prove everyone wrong... again.
01/22/2025
3:25 PM
Avidity Biosciences (Subject)
Gallagher Kathleen P. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/08/2025
7:35 PM
Avidity Biosciences (Issuer)
Flanagan W. Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2025
7:22 PM
Avidity Biosciences (Issuer)
Hughes Steven George (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2025
7:24 PM
Avidity Biosciences (Issuer)
Boyce Sarah (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2025
7:26 PM
Avidity Biosciences (Issuer)
MacLean Michael F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2025
7:29 PM
Avidity Biosciences (Issuer)
Moriarty John B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2025
7:31 PM
Avidity Biosciences (Issuer)
McCarthy Teresa (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2025
7:13 PM
Avidity Biosciences (Issuer)
Calderaro Charles III (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2025
7:14 PM
Avidity Biosciences (Issuer)
Mosbrooker Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2025
7:16 PM
Avidity Biosciences (Issuer)
Gallagher Kathleen P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2025
5:52 PM
Avidity Biosciences (Issuer)
Gallagher Kathleen P. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/08/2025
6:04 PM
Avidity Biosciences (Issuer)
Mosbrooker Eric (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/08/2025
5:42 PM
Avidity Biosciences (Issuer)
Calderaro Charles III (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/08/2025
5:46 PM
Avidity Biosciences (Issuer)
Hughes Steven George (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/08/2025
8:02 AM
Avidity Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/19/2024
5:15 PM
Avidity Biosciences (Issuer)
McCarthy Teresa (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2024
5:15 PM
Avidity Biosciences (Issuer)
Boyce Sarah (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2024
5:16 PM
Avidity Biosciences (Issuer)
MacLean Michael F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2024
5:17 PM
Avidity Biosciences (Issuer)
Flanagan W. Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2024
3:46 PM
Avidity Biosciences (Issuer)
McCarthy Teresa (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2024
5:08 PM
Avidity Biosciences (Issuer)
Flanagan W. Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2024
3:59 PM
Avidity Biosciences (Subject)
Flanagan W. Michael (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/20/2024
5:06 PM
Avidity Biosciences (Issuer)
LEVIN ARTHUR A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2024
5:10 PM
Avidity Biosciences (Issuer)
McCarthy Teresa (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2024
4:46 PM
Avidity Biosciences (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Form SC 13G/A
11/14/2024
8:39 AM
Avidity Biosciences (Subject)
Avoro Capital Advisors LLC (Filed by)
Form SC 13G
11/12/2024
6:06 AM
Avidity Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/08/2024
3:50 PM
Avidity Biosciences (Issuer)
MacLean Michael F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2024
12:56 PM
Avidity Biosciences (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G
11/04/2024
9:22 AM
Avidity Biosciences (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
10/30/2024
7:01 AM
Avidity Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/23/2024
3:19 PM
Avidity Biosciences (Issuer)
LEVIN ARTHUR A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/21/2024
3:21 PM
Avidity Biosciences (Subject)
LEVIN ARTHUR A (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/17/2024
3:20 PM
Avidity Biosciences (Issuer)
McCarthy Teresa (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/16/2024
12:48 PM
Avidity Biosciences (Subject)
LEVIN ARTHUR A (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/09/2024
4:23 PM
Avidity Biosciences (Issuer)
Thompson Tamar (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2024
6:02 AM
Avidity Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/01/2024
3:36 PM
Avidity Biosciences (Subject)
Flanagan W. Michael (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/23/2024
7:59 PM
Avidity Biosciences (Issuer)
MacLean Michael F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/23/2024
8:01 PM
Avidity Biosciences (Issuer)
Boyce Sarah (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/23/2024
8:03 PM
Avidity Biosciences (Issuer)
Flanagan W. Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/23/2024
8:06 PM
Avidity Biosciences (Issuer)
McCarthy Teresa (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/23/2024
3:27 PM
Avidity Biosciences (Subject)
Flanagan W. Michael (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/20/2024
4:19 PM
Avidity Biosciences (Issuer)
LEVIN ARTHUR A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2024
3:25 PM
Avidity Biosciences (Issuer)
Flanagan W. Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2024
3:18 PM
Avidity Biosciences (Subject)
McCarthy Teresa (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/11/2024
3:18 PM
Avidity Biosciences (Subject)
Flanagan W. Michael (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/10/2024
5:26 PM
Avidity Biosciences (Issuer)
LEVIN ARTHUR A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/23/2024
4:46 PM
Avidity Biosciences (Subject)
RTW INVESTMENTS, LP (Filed by)
Form SC 13D/A
08/21/2024
3:30 PM
Avidity Biosciences (Issuer)
LEVIN ARTHUR A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
The Trump Dump is starting; Get out of stocks now? (Ad)

The first 365 days of the Trump presidency… Will be the best time to get rich in American history.

If I’m right about this (like I was before) a modest $900 investment could grow to a life-changing a
08/15/2024
3:43 PM
Avidity Biosciences (Filer)
Form 424B5
08/15/2024
3:46 PM
Avidity Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/13/2024
3:20 PM
Avidity Biosciences (Filer)
Form 424B5
08/09/2024
4:12 PM
Avidity Biosciences (Filer)
Form 424B5
08/09/2024
3:20 PM
Avidity Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/09/2024
3:23 PM
Avidity Biosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/09/2024
6:02 AM
Avidity Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2024
4:46 PM
Avidity Biosciences (Issuer)
Boyce Sarah (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2024
8:11 AM
Avidity Biosciences (Issuer)
Moriarty John B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:RNA) was last updated on 7/5/2025 by MarketBeat.com Staff
From Our Partners